Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: misti30 who wrote (3017)	4/13/2000 2:50:00 PM
From: Don Hurst	Respond to of 5665

Misti, can you make your intuition move the date up to mid May. I have some out of the money May calls that could use some help from your intuition. Grin.... Regards, Don

To: misti30 who wrote (3017)	4/14/2000 12:57:00 AM
From: Gary Mohilner	Read Replies (2) \| Respond to of 5665

Misti, I think a number of good things could happen by June. One reason is June is the end of IMGN's fiscal year, so I believe there'll be a big push to finish partnerships and make any new drug announcements prior to the end of June so they can be reflected in the Annual Report. Their Partnership with BCHE should be renewed by the end of June as well. If it's not renewed BCHE would lose the rights to the screens that have already been provided, and as we've heard, they've developed drugs using those screens, so a renewal of the partnership is almost a certainty. Finally, by June we'll be at the six month point on the Phase 1/2 Trial. They may not have yet achieved complete remissions by then, but I strongly believe that efficacy will have been demonstrated by then, and I think they'll tell us so. Gary